| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/11/1996 | CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
| 06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 06/06/1996 | WO1996016970A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 06/06/1996 | WO1996016955A1 Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 06/06/1996 | WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p |
| 06/06/1996 | WO1996016654A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 06/06/1996 | CA2205950A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 06/06/1996 | CA2205800A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
| 06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
| 06/05/1996 | EP0714408A1 Tryptase inhibitor |
| 06/05/1996 | EP0714404A1 Anti-inflammatory peptides |
| 06/05/1996 | EP0714392A1 Heterocycles useful as neurokinin antagonists |
| 06/05/1996 | EP0450039B1 Dihydro-1,2 oxo-2 quinoxaline derivates, their preparation and their application in therapeutics |
| 05/30/1996 | WO1996016087A1 G-protein coupled receptor |
| 05/30/1996 | WO1996016084A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 05/30/1996 | WO1996016080A1 Human neutrophil elastase inhibitors |
| 05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 05/30/1996 | CA2205540A1 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 05/29/1996 | EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them |
| 05/29/1996 | EP0713653A1 Fortified fruit juice |
| 05/29/1996 | EP0713394A1 Method of preventing neutrophil mediated connective tissue damage |
| 05/29/1996 | CN1123141A Aerosol preparation and preparation method thereof |
| 05/28/1996 | US5521315 Olefin substituted long chain compounds |
| 05/28/1996 | US5521213 Nonsteroid antiinflammatory agents |
| 05/28/1996 | US5521207 Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 05/28/1996 | US5521206 Hypotensive agents, treatment of atherosclerosis |
| 05/28/1996 | US5521199 Piperidinyl compounds as neurokinin receptor antagonists |
| 05/28/1996 | US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome |
| 05/28/1996 | US5521173 Tricyclic benzazepine vasopressin antagonists |
| 05/28/1996 | US5521157 Modified polypeptide compound with VIP-like activity |
| 05/28/1996 | US5521156 Cyclic neurokinin A antagonists |
| 05/28/1996 | CA1338352C 2-substituted quinolines |
| 05/25/1996 | CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/24/1996 | CA2163466A1 Fortified fruit juices |
| 05/23/1996 | WO1996015126A1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum |
| 05/23/1996 | WO1996015125A1 Nonpeptide endothelin antagonists |
| 05/23/1996 | WO1996015109A1 Endothelin antagonists |
| 05/23/1996 | WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 05/23/1996 | WO1996009831A3 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 05/23/1996 | CA2204898A1 Methods of inhibiting pneumocystis carini pneumonia, giardia lamblia, and cryptosporidum parvum and compounds useful therefor |
| 05/23/1996 | CA2202051A1 Nonpeptide endothelin antagonists |
| 05/21/1996 | US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/21/1996 | US5519022 α, α dialkylbenzyl derivatives |
| 05/21/1996 | CA2017573C 4-(hydroxydiphenylmethyl)-1-piperidylphenylalkane derivatives as antihistamines and a method of treatment of an allergic response |
| 05/18/1996 | CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 05/17/1996 | WO1996014409A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 05/17/1996 | WO1996014339A1 Antibodies |
| 05/17/1996 | WO1996014318A1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 05/17/1996 | WO1996014317A1 Novel piperidine derivatives with paf antagonist activity |
| 05/17/1996 | WO1996014078A1 Extract of crataegus, process for producing it and its use |
| 05/17/1996 | WO1996014069A1 Percutaneously absorbable patch |
| 05/17/1996 | WO1996004266A3 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 05/17/1996 | CA2204511A1 Production of recombinant peptides as natural hydrophobic peptide analorues |
| 05/17/1996 | CA2203368A1 Extract of crataegus, process for producing it and its use |
| 05/15/1996 | EP0711289A1 Piperazine compounds used in therapy |
| 05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
| 05/15/1996 | EP0711280A1 Perhydroisoindole derivatives as p substance antagonists |
| 05/15/1996 | EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
| 05/15/1996 | CN1122246A Snow Ganoderma lucidum oral liquid |
| 05/15/1996 | CN1122245A Snow Ganoderma lucidum solid medicament |
| 05/14/1996 | US5516907 Antiinflammatory agents |
| 05/14/1996 | US5516783 Platelet activating factor |
| 05/14/1996 | US5516774 Treating diseases characterized by excess renal reabsorption of water |
| 05/09/1996 | WO1996013491A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 05/09/1996 | WO1996013266A1 Boronic ester and acid compounds, synthesis and uses |
| 05/08/1996 | EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 05/08/1996 | EP0710235A1 Endothelin antagonists |
| 05/08/1996 | EP0710227A1 Vitamin d analogues |
| 05/08/1996 | EP0580648B1 Process for conditioning of water-soluble substances |
| 05/08/1996 | CN1122108A Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract |
| 05/07/1996 | US5514687 Benzopyrido piperidylidene compounds, compositions, methods of manufacture and method of use |
| 05/07/1996 | US5514685 Antiinflammatory antoproliferative agents, immunosuppressants |
| 05/07/1996 | US5514204 Adsorption |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | WO1996012724A1 Novel quinoxalindione derivatives, their production and use in medicaments |
| 05/02/1996 | WO1996012720A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 05/02/1996 | WO1996012491A1 Method of inhibiting conditions associated with bradykinin |
| 05/02/1996 | WO1996012470A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| 05/02/1996 | DE4439492A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments |
| 05/02/1996 | CA2203914A1 Method of inhibiting conditions associated with bradykinin |
| 05/02/1996 | CA2203656A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203118A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| 05/01/1996 | EP0709382A1 Aromatic dibenzofurane derivatives, pharmaceutical and cosmetic compositions containing them |
| 05/01/1996 | EP0709376A2 Therapeutic compounds |
| 05/01/1996 | EP0709375A2 Therapeutic heterocycles |
| 05/01/1996 | EP0708776A1 Antiallergic imidazoazepines |
| 05/01/1996 | EP0708771A1 Benzyloxyquinuclidines as substance p antagonists |
| 05/01/1996 | EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 05/01/1996 | CN1121715A 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors |
| 04/30/1996 | US5512594 Administering to treat a medical condition mediated by one or more leukotrienes |
| 04/30/1996 | US5512581 Antiinflammatory agent |
| 04/30/1996 | US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists |
| 04/30/1996 | US5512563 Tricyclic benzazepine vasopressin antagonists |
| 04/30/1996 | US5512270 Respiratory system disorders, parkinson's disease, gastrointestinal disorders |
| 04/30/1996 | US5512269 Method of treating retained pulmonary secretions |
| 04/30/1996 | CA1338287C Hetrazepines and processes for preparing them |